106 related articles for article (PubMed ID: 33539684)
21. The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma.
Li J; Li Z; Wu Y; Wang Y; Wang D; Zhang W; Yuan H; Ye J; Song X; Yang J; Jiang H; Cheng J
Cell Death Dis; 2019 Aug; 10(8):603. PubMed ID: 31399556
[TBL] [Abstract][Full Text] [Related]
22. TAZ sensitizes EGFR wild-type non-small-cell lung cancer to gefitinib by promoting amphiregulin transcription.
Yuan W; Xu W; Li Y; Jiang W; Li Y; Huang Q; Chen B; Wu S; Wang Y; Song W; Zhao W; Wu J
Cell Death Dis; 2019 Mar; 10(4):283. PubMed ID: 30911072
[TBL] [Abstract][Full Text] [Related]
23. Scutellariabarbata D. Don extraction selectively targets stemness-prone NSCLC cells by attenuating SOX2/SMO/GLI1 network loop.
Chen WW; Gong KK; Yang LJ; Dai JJ; Zhang Q; Wang F; Li XL; Xi SC; Du J
J Ethnopharmacol; 2021 Jan; 265():113295. PubMed ID: 32841701
[TBL] [Abstract][Full Text] [Related]
24. GnRH participates in the self-renewal of A549-derived lung cancer stem-like cells through upregulation of the JNK signaling pathway.
Lu C; Huang T; Chen W; Lu H
Oncol Rep; 2015 Jul; 34(1):244-50. PubMed ID: 25955300
[TBL] [Abstract][Full Text] [Related]
25. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
[TBL] [Abstract][Full Text] [Related]
26. Curcumin induces apoptosis and inhibits growth of orthotopic human non-small cell lung cancer xenografts.
Lev-Ari S; Starr A; Katzburg S; Berkovich L; Rimmon A; Ben-Yosef R; Vexler A; Ron I; Earon G
J Nutr Biochem; 2014 Aug; 25(8):843-50. PubMed ID: 24835302
[TBL] [Abstract][Full Text] [Related]
27. SKIL facilitates tumorigenesis and immune escape of NSCLC via upregulating TAZ/autophagy axis.
Ma F; Ding MG; Lei YY; Luo LH; Jiang S; Feng YH; Liu XL
Cell Death Dis; 2020 Dec; 11(12):1028. PubMed ID: 33268765
[TBL] [Abstract][Full Text] [Related]
28. Targeting stemness is an effective strategy to control EML4-ALK+ non-small cell lung cancer cells.
Oh SJ; Noh KH; Lee YH; Hong SO; Song KH; Lee HJ; Kim S; Kim TM; Jeon JH; Seo JH; Kim DW; Kim TW
Oncotarget; 2015 Nov; 6(37):40255-67. PubMed ID: 26517679
[TBL] [Abstract][Full Text] [Related]
29. Curcumin inhibits the growth via Wnt/β-catenin pathway in non-small-cell lung cancer cells.
Wang JY; Wang X; Wang XJ; Zheng BZ; Wang Y; Wang X; Liang B
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7492-7499. PubMed ID: 30468498
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of p38 MAPK contributes to stem cell-like properties of non-small cell lung cancer.
Fang Y; Wang J; Wang G; Zhou C; Wang P; Zhao S; Zhao S; Huang S; Su W; Jiang P; Chang A; Xiang R; Sun P
Oncotarget; 2017 Apr; 8(16):26702-26717. PubMed ID: 28460458
[TBL] [Abstract][Full Text] [Related]
31. Curcumin Inhibits the Tumorigenesis of Breast Cancer by Blocking Tafazzin/Yes-Associated Protein Axis.
Shen Y; Han Z; Liu S; Jiao Y; Li Y; Yuan H
Cancer Manag Res; 2020; 12():1493-1502. PubMed ID: 32161501
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
[TBL] [Abstract][Full Text] [Related]
33. Curcumin lowers erlotinib resistance in non-small cell lung carcinoma cells with mutated EGF receptor.
Li S; Liu Z; Zhu F; Fan X; Wu X; Zhao H; Jiang L
Oncol Res; 2013; 21(3):137-44. PubMed ID: 24512728
[TBL] [Abstract][Full Text] [Related]
34. SET Domain-Containing Protein 5 Enhances the Cell Stemness of Non-Small Cell Lung Cancer via the PI3K/Akt/mTOR Pathway.
Chen Q; Sun Z; Li J; Zhang D; Guo B; Zhang T
J Environ Pathol Toxicol Oncol; 2021; 40(2):55-63. PubMed ID: 33822517
[TBL] [Abstract][Full Text] [Related]
35. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
Wang HJ; Yang ZX; Dai XT; Chen YF; Yang HP; Zhou XD
Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094
[TBL] [Abstract][Full Text] [Related]
36. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
Juan WC; Hong W
Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
[TBL] [Abstract][Full Text] [Related]
37. Validation of chemical compound library screening for transcriptional co-activator with PDZ-binding motif inhibitors using GFP-fused transcriptional co-activator with PDZ-binding motif.
Nagashima S; Maruyama J; Kawano S; Iwasa H; Nakagawa K; Ishigami-Yuasa M; Kagechika H; Nishina H; Hata Y
Cancer Sci; 2016 Jun; 107(6):791-802. PubMed ID: 27009852
[TBL] [Abstract][Full Text] [Related]
38. Curcumin Inhibits Non-Small Cell Lung Cancer Cells Metastasis through the Adiponectin/NF-κb/MMPs Signaling Pathway.
Tsai JR; Liu PL; Chen YH; Chou SH; Cheng YJ; Hwang JJ; Chong IW
PLoS One; 2015; 10(12):e0144462. PubMed ID: 26656720
[TBL] [Abstract][Full Text] [Related]
39. Curcumin inhibits proliferation-migration of NSCLC by steering crosstalk between a Wnt signaling pathway and an adherens junction via EGR-1.
Chen QY; Jiao DM; Wang LF; Wang L; Hu HZ; Song J; Yan J; Wu LJ; Shi JG
Mol Biosyst; 2015 Mar; 11(3):859-68. PubMed ID: 25578635
[TBL] [Abstract][Full Text] [Related]
40. Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway.
Chen P; Li J; Jiang HG; Lan T; Chen YC
Tumour Biol; 2015 May; 36(5):3591-9. PubMed ID: 25542235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
